These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37801907)

  • 41. Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications.
    Potrykus M; Czaja-Stolc S; Stankiewicz M; Kaska Ł; Małgorzewicz S
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors' Combination.
    Quesada-Vázquez S; Bone C; Saha S; Triguero I; Colom-Pellicer M; Aragonès G; Hildebrand F; Del Bas JM; Caimari A; Beraza N; Escoté X
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epithelial Barrier: Protector and Trigger of Allergic Disorders.
    Izquierdo E; Rodriguez-Coira J; Delgado-Dolset MI; Gomez-Casado C; Barber D; Escribese MM
    J Investig Allergol Clin Immunol; 2022 Apr; 32(2):81-96. PubMed ID: 35029152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
    de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
    Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The gut barrier and chronic diseases.
    Santilli A; Stefanopoulos S; Cresci GAM
    Curr Opin Clin Nutr Metab Care; 2022 May; 25(3):178-185. PubMed ID: 35125386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypertension promotes microbial translocation and dysbiotic shifts in the fecal microbiome of nonhuman primates.
    Vemuri R; Ruggiero A; Whitfield JM; Dugan GO; Cline JM; Block MR; Guo H; Kavanagh K
    Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H474-H485. PubMed ID: 35148233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microbial translocation and microbiome dysbiosis in HIV-associated immune activation.
    Zevin AS; McKinnon L; Burgener A; Klatt NR
    Curr Opin HIV AIDS; 2016 Mar; 11(2):182-90. PubMed ID: 26679414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Azoxystrobin Disrupts Colonic Barrier Function in Mice
    Meng Z; Yan Z; Sun W; Bao X; Feng W; Gu Y; Tian S; Wang J; Chen X; Zhu W
    J Agric Food Chem; 2023 Jan; 71(1):789-801. PubMed ID: 36594455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The origins of allergy from a systems approach.
    Krempski JW; Dant C; Nadeau KC
    Ann Allergy Asthma Immunol; 2020 Nov; 125(5):507-516. PubMed ID: 32702411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease.
    Steelant B; Seys SF; Boeckxstaens G; Akdis CA; Ceuppens JL; Hellings PW
    Rhinology; 2016 Sep; 54(3):195-205. PubMed ID: 27316042
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelial barriers in allergy and asthma.
    Hellings PW; Steelant B
    J Allergy Clin Immunol; 2020 Jun; 145(6):1499-1509. PubMed ID: 32507228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Involvement and repair of epithelial barrier dysfunction in allergic diseases.
    Lu HF; Zhou YC; Yang LT; Zhou Q; Wang XJ; Qiu SQ; Cheng BH; Zeng XH
    Front Immunol; 2024; 15():1348272. PubMed ID: 38361946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potential role of the skin microbiota in Inflammatory skin diseases.
    Chen P; He G; Qian J; Zhan Y; Xiao R
    J Cosmet Dermatol; 2021 Feb; 20(2):400-409. PubMed ID: 32562332
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent insights into the role of the microbiome in malignant and benign hematologic diseases.
    Fattizzo B; Cavallaro F; Folino F; Barcellini W
    Crit Rev Oncol Hematol; 2021 Apr; 160():103289. PubMed ID: 33667659
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Skin microbiome dysbiosis and the role of Staphylococcus aureus in atopic dermatitis in adults and children: A narrative review.
    Demessant-Flavigny AL; Connétable S; Kerob D; Moreau M; Aguilar L; Wollenberg A
    J Eur Acad Dermatol Venereol; 2023 Jun; 37 Suppl 5():3-17. PubMed ID: 37232427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin Barrier Function and the Microbiome.
    Lee HJ; Kim M
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epithelial barrier theory in the context of nutrition and environmental exposure in athletes.
    Kistler W; Villiger M; Villiger B; Yazici D; Pat Y; Mitamura Y; Ardicli S; Skolnick S; Dhir R; Akdis M; Nadeau K; Ogulur I; Akdis CA
    Allergy; 2024 Jul; ():. PubMed ID: 39011970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Using the Microbiome as a Regenerative Medicine Strategy for Autoimmune Diseases.
    Williams KL; Enslow R; Suresh S; Beaton C; Hodge M; Brooks AE
    Biomedicines; 2023 May; 11(6):. PubMed ID: 37371676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transepithelial Barrier Dysfunction Drives Microbiota Dysbiosis to Initiate Epithelial Clock-driven Inflammation.
    Pai YC; Li YH; Turner JR; Yu LC
    J Crohns Colitis; 2023 Oct; 17(9):1471-1488. PubMed ID: 37004200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.